Nevanimibe hydrochloride
≥99%
- Product Code: 101644
CAS:
133825-81-7
Molecular Weight: | 458.08 g./mol | Molecular Formula: | C₂₇H₄₀ClN₃O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
Nevanimibe hydrochloride is primarily used in the treatment of congenital adrenal hyperplasia (CAH), a genetic disorder affecting the adrenal glands. It works by inhibiting an enzyme involved in the production of adrenal hormones, helping to manage hormone imbalances. Additionally, it has potential applications in addressing Cushing's syndrome, a condition caused by excessive cortisol levels, by regulating steroidogenesis. Its therapeutic role is significant in reducing the overproduction of androgens and cortisol, thereby alleviating symptoms associated with these endocrine disorders.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | $1,170.11 |
+
-
|
0.010 | 10-20 days | $1,856.03 |
+
-
|
Nevanimibe hydrochloride
Nevanimibe hydrochloride is primarily used in the treatment of congenital adrenal hyperplasia (CAH), a genetic disorder affecting the adrenal glands. It works by inhibiting an enzyme involved in the production of adrenal hormones, helping to manage hormone imbalances. Additionally, it has potential applications in addressing Cushing's syndrome, a condition caused by excessive cortisol levels, by regulating steroidogenesis. Its therapeutic role is significant in reducing the overproduction of androgens and cortisol, thereby alleviating symptoms associated with these endocrine disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :